Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

377 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. III. Comparative performance characteristics of academic and manufacturers' laboratories.
Fritzler MJ, Wiik A, Tan EM, Smolen JS, McDougal JS, Chan EK, Gordon TP, Hardin JA, Kalden JR, Lahita RG, Maini RN, Reeves WH, Rothfield NF, Takasaki Y, Wilson M, Byrd MG, Slivka L, Koziol JA. Fritzler MJ, et al. Among authors: maini rn. J Rheumatol. 2003 Nov;30(11):2374-81. J Rheumatol. 2003. PMID: 14677180
Reference sera for antinuclear antibodies. II. Further definition of antibody specificities in international antinuclear antibody reference sera by immunofluorescence and western blotting.
Smolen JS, Butcher B, Fritzler MJ, Gordon T, Hardin J, Kalden JR, Lahita R, Maini RN, Reeves W, Reichlin M, Rothfield N, Takasaki Y, van Venrooij WJ, Tan EM. Smolen JS, et al. Among authors: maini rn. Arthritis Rheum. 1997 Mar;40(3):413-8. doi: 10.1002/art.1780400304. Arthritis Rheum. 1997. PMID: 9082926
A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities. I. Precision, sensitivity, and specificity.
Tan EM, Smolen JS, McDougal JS, Butcher BT, Conn D, Dawkins R, Fritzler MJ, Gordon T, Hardin JA, Kalden JR, Lahita RG, Maini RN, Rothfield NF, Smeenk R, Takasaki Y, van Venrooij WJ, Wiik A, Wilson M, Koziol JA. Tan EM, et al. Among authors: maini rn. Arthritis Rheum. 1999 Mar;42(3):455-64. doi: 10.1002/1529-0131(199904)42:3<455::AID-ANR10>3.0.CO;2-3. Arthritis Rheum. 1999. PMID: 10088768 Free article.
Range of antinuclear antibodies in "healthy" individuals.
Tan EM, Feltkamp TE, Smolen JS, Butcher B, Dawkins R, Fritzler MJ, Gordon T, Hardin JA, Kalden JR, Lahita RG, Maini RN, McDougal JS, Rothfield NF, Smeenk RJ, Takasaki Y, Wiik A, Wilson MR, Koziol JA. Tan EM, et al. Among authors: maini rn. Arthritis Rheum. 1997 Sep;40(9):1601-11. doi: 10.1002/art.1780400909. Arthritis Rheum. 1997. PMID: 9324014
Interleukin-6: a new therapeutic target.
Smolen JS, Maini RN. Smolen JS, et al. Among authors: maini rn. Arthritis Res Ther. 2006;8 Suppl 2(Suppl 2):S5. doi: 10.1186/ar1969. Epub 2006 Jul 28. Arthritis Res Ther. 2006. PMID: 16899109 Free PMC article. Review.
Antinuclear antibody determination methods.
Williams DG, Charles PJ, Field M, Chua SM, Maini RN. Williams DG, et al. Among authors: maini rn. Clin Rheumatol. 1990 Mar;9(1 Suppl 1):51-60. doi: 10.1007/BF02205552. Clin Rheumatol. 1990. PMID: 2203594 Review.
Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial.
St Clair EW, van der Heijde DM, Smolen JS, Maini RN, Bathon JM, Emery P, Keystone E, Schiff M, Kalden JR, Wang B, Dewoody K, Weiss R, Baker D; Active-Controlled Study of Patients Receiving Infliximab for the Treatment of Rheumatoid Arthritis of Early Onset Study Group. St Clair EW, et al. Among authors: maini rn. Arthritis Rheum. 2004 Nov;50(11):3432-43. doi: 10.1002/art.20568. Arthritis Rheum. 2004. PMID: 15529377 Free article. Clinical Trial.
377 results